Intranasal vaccination of pups with maternally derived antibodies with a modified live canine parvovirus

C Buonavoglia; A Cavalli; E Gravino; V Voigt; D Buonavoglia; D de Caprariis

doi:10.1111/j.1439-0450.1994.tb00199.x

Intranasal vaccination of pups with maternally derived antibodies with a modified live canine parvovirus

Zentralbl Veterinarmed B. 1994 Mar;41(1):3-8. doi: 10.1111/j.1439-0450.1994.tb00199.x.

Authors

C Buonavoglia¹, A Cavalli, E Gravino, V Voigt, D Buonavoglia, D de Caprariis

Affiliation

¹ Istituto di Malattie Infettive e Parassitarie degli Animali, Facoltà di Medicina Veterinaria, Università Bari, Italia.

PMID: 7941844
DOI: 10.1111/j.1439-0450.1994.tb00199.x

Abstract

The modified live canine parvovirus (CPV) vaccine was used to vaccinate intranasally twenty-five pups with maternal antibody. The vaccine was able to overcome the interference of maternal immunity in rates of 100%, 72.7% and 17.6% in pups with haemagglutination inhibition antibody titre of 40, 80 and 160 respectively.

MeSH terms

Administration, Intranasal
Animals
Antibodies, Viral / blood
Dog Diseases / immunology
Dog Diseases / prevention & control*
Dogs
Immunity, Maternally-Acquired*
Parvoviridae Infections / immunology
Parvoviridae Infections / prevention & control
Parvoviridae Infections / veterinary*
Parvovirus, Canine / immunology*
Vaccination / veterinary
Viral Vaccines / administration & dosage
Viral Vaccines / immunology*

Substances

Antibodies, Viral
Viral Vaccines